Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 bi…
financialpost.com
Feb 23, 2026
''(Bloomberg) — Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.
An IPO of that size would be Canada’s largest debut since 2021. RBC Capital Markets, Jefferies Financial Group and TD Securities are advising on the transaction, people familiar with the offering have said.''
'Apotex is considering an offering that would raise C$750 million to C$1 billion, the people said. At the top of the range, it would be the biggest Canadian new listing since Definity Financial Corp. raised about C$1.6 billion in November 2021. '